Skip to Content

Symlin Approval History

FDA Approved: Yes (First approved March 16, 2005)
Brand name: Symlin
Generic name: pramlintide acetate
Dosage form: Injection
Company: Amylin Pharmaceuticals, Inc.
Treatment for: Diabetes, Type 1, Diabetes, Type 2

Symlin (pramlintide acetate) is an antihyperglycemic drug for use in patients with diabetes treated with insulin.

Development History and FDA Approval Process for Symlin

DateArticle
Oct  1, 2007Approval FDA Approves Symlin Pen-Injector Devices Offering Convenience andAccuracy for Symlin Use
Mar 16, 2005Approval Symlin Amylin Pharmaceuticals, Inc. - Treatment for Diabetes in conjunction with insulin
Sep 30, 2004Amylin Pharmaceuticals Submits Complete Response to FDA for Symlin

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide